ProfileGDS4718 / 234562_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 65% 46% 58% 70% 53% 49% 44% 50% 47% 54% 71% 56% 49% 59% 49% 36% 56% 50% 88% 48% 45% 46% 54% 64% 48% 54% 75% 67% 61% 54% 50% 69% 51% 50% 32% 65% 54% 51% 36% 52% 64% 52% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6589267
GSM549102patient 115, normal, homogenized [OPG study]6.4514465
GSM549104patient 119, normal, homogenized [OPG study]5.3086946
GSM549108patient 138, normal, homogenized [OPG study]5.9903758
GSM549119patient 077, normal, homogenized [OPG study]6.8479470
GSM549133patient 032, cancer, homogenized [OPG study]5.6389753
GSM549139patient 042, cancer, homogenized [OPG study]5.4153849
GSM549099patient 107, normal, homogenized [OPG study]5.1866544
GSM549109patient 139, normal, homogenized [OPG study]5.5331650
GSM549110patient 046, normal, homogenized [OPG study]5.3344647
GSM549114patient 063, normal, homogenized [OPG study]5.6851554
GSM549122patient 082, normal, homogenized [OPG study]6.9995371
GSM549134patient 033, cancer, homogenized [OPG study]5.8384856
GSM549136patient 036, cancer, homogenized [OPG study]5.4125349
GSM549140patient 044, cancer, homogenized [OPG study]6.0212859
GSM549111patient 047, normal, homogenized [OPG study]5.4597949
GSM549113patient 057, normal, homogenized [OPG study]4.7376236
GSM549132patient 031, cancer, homogenized [OPG study]5.8657156
GSM549137patient 038, cancer, homogenized [OPG study]5.4830750
GSM549142patient 047, cancer, homogenized [OPG study]8.4843888
GSM549100patient 110, normal, homogenized [OPG study]5.4297548
GSM549107patient 135, normal, homogenized [OPG study]5.2264645
GSM549115patient 068, normal, homogenized [OPG study]5.238446
GSM549116patient 072, normal, homogenized [OPG study]5.7594654
GSM549120patient 078, normal, homogenized [OPG study]6.4389364
GSM549131patient 030, cancer, homogenized [OPG study]5.339148
GSM549118patient 074, normal, homogenized [OPG study]5.729854
GSM549129patient 027, cancer, homogenized [OPG study]7.3539175
GSM549123patient 088, normal, homogenized [OPG study]6.6189167
GSM549124patient 006, cancer, homogenized [OPG study]6.2107261
GSM549126patient 015, cancer, homogenized [OPG study]5.7198254
GSM549128patient 025, cancer, homogenized [OPG study]5.4998250
GSM549103patient 117, normal, homogenized [OPG study]6.7261669
GSM549117patient 073, normal, homogenized [OPG study]5.5378651
GSM549138patient 041, cancer, homogenized [OPG study]5.4783450
GSM549141patient 045, cancer, homogenized [OPG study]4.5810532
GSM549130patient 028, cancer, homogenized [OPG study]6.4710765
GSM549101patient 111, normal, homogenized [OPG study]5.7497754
GSM549105patient 128, normal, homogenized [OPG study]5.5643551
GSM549106patient 134, normal, homogenized [OPG study]4.7693136
GSM549112patient 048, normal, homogenized [OPG study]5.5963252
GSM549125patient 011, cancer, homogenized [OPG study]6.4182864
GSM549127patient 024, cancer, homogenized [OPG study]5.6730652
GSM549135patient 035, cancer, homogenized [OPG study]5.2177445